Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XC8 in Eosinophilic Bronchial Asthma
NCT04674137Phase 2Completed
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of histamine glutarimide in eosinophilic asthma (EA). Started Dec 2020; status: completed.
02
Drugs
histamine glutarimide
03
Conditions
eosinophilic asthma (EA)
Beyond the preview
Go deeper on NCT04674137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674137.